NEW YORK (GenomeWeb News) The Center for Vaccine Development at the University of Maryland’s School of Medicine said today that it has been awarded a $5.6 million grant from the Bill and Melinda Gates Foundation to develop a diagnostic for diarrheal disease.
Illumina and Ibis Biosciences will serve as subcontractors on the grant and will provide genomics and pathogenic identification services, the university said.
The center plans to develop a diagnostic that will be faster and more accurate than available models and will be aimed at identifying pathogens that cause diarrheal problems in developing countries.
This center will “detect all of the important organisms involved in diarrheal diseases in developing countries,” the CVD said in a statement.
The research will be conducted on fecal samples obtained from Bangladesh, Mali, and Kenya through an agreement with researchers from the Center for Vaccine Development.